Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Contract manufacturing services provider JHP Pharmaceuticals has signed a multi-year agreement with an undisclosed biotechnology company.
Subscribe to our email newsletter
Under the agreement, JHP Pharma will be responsible for manufacturing and supply of an approved therapy used in cancer patients.
JHP Pharma manufactures sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.
JHP Pharma president and co-founder Stuart Hinchen said this will be the second multi-year contract JHP has entered during the last two months.
"These agreements are examples of how our approach to ongoing investment in our people and facilities allow us to focus on customer needs which results in rising, sustainable growth," Hinchen said.
"Our Rochester, Michigan manufacturing site has a solid history of successful partnerships, manufacturing both clinical and commercial products."